• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Recombinant fibrinogen, gamma275Arg-->Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions.

作者信息

Ishikawa S, Hirota-Kawadobora M, Tozuka M, Ishii K, Terasawa F, Okumura N

机构信息

Department of Aging Biology, Shinshu University School of Medicine, Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan.

出版信息

J Thromb Haemost. 2004 Mar;2(3):468-75. doi: 10.1111/j.1538-7836.2004.00600.x.

DOI:10.1111/j.1538-7836.2004.00600.x
PMID:15009465
Abstract

BACKGROUND AND OBJECTIVES

Analysis of dysfibrinogens has provided useful information aiding our understanding of molecular defects in fibrin polymerization. We have already reported impaired fibrin polymerization in a variant fibrinogen (gammaArg275Cys), the Cys being located in the D:D interface. Since this substitution occurred in a heterozygous individual, interpretation of the functional analysis was complicated. We tried to resolve this complication by synthesizing a recombinant variant fibrinogen.

METHODS

A variant gamma-chain expression plasmid was transfected into Chinese hamster ovary cells expressing normal human fibrinogen Aalpha- and Bbeta-chains. The recombinant variant fibrinogen (gamma275C) was purified using an immunoaffinity column, and we compared its structure and functions with those of normal recombinant fibrinogen (gamma275R) and plasma variant fibrinogen.

RESULTS

Mass analyses showed the existence of disulfide-linked Cys in both patient and recombinant variant fibrinogens. Functional analyses indicated that both fibrin polymerization and gamma-gamma dimer formation were markedly impaired in the variant fibrinogen. The impairments were much more pronounced in gamma275C than in plasma variant fibrinogen. In addition, scanning electron microscopic observation of fibrin clots made from gamma275C revealed less dense fibrin fiber bundles and larger fiber diameter than in those made from gamma275R, and also the existence of many aberrant fibrin fibers with tapered ends.

CONCLUSIONS

These results indicate that gammaArg275 has an important residue affecting the structure and function of the gamma-chain C-terminal domain. However, the variant D:D interface can interact with that of the normal fibrinogen existing in a heterozygous patient with dysfibrinogenemia.

摘要

相似文献

1
Recombinant fibrinogen, gamma275Arg-->Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions.
J Thromb Haemost. 2004 Mar;2(3):468-75. doi: 10.1111/j.1538-7836.2004.00600.x.
2
Comparison of thrombin-catalyzed fibrin polymerization and factor XIIIa-catalyzed cross-linking of fibrin among three recombinant variant fibrinogens, gamma 275C, gamma 275H, and gamma 275A.三种重组变体纤维蛋白原γ275C、γ275H和γ275A中凝血酶催化的纤维蛋白聚合与因子XIIIa催化的纤维蛋白交联的比较。
J Thromb Haemost. 2004 Aug;2(8):1359-67. doi: 10.1111/j.1538-7836.2004.00844.x.
3
Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.重组Bβ15C和Bβ15A纤维蛋白原的功能分析表明,Bβ15G残基在纤维蛋白原β链释放和原纤维横向聚集中起重要作用。
J Thromb Haemost. 2005 May;3(5):983-90. doi: 10.1111/j.1538-7836.2005.01294.x.
4
[Functional analysis of heterozygous plasma dysfibrinogens derived from two families of gammaArg275Cys and three families of gammaArg275His, and haplotype analysis for these families].
Rinsho Byori. 2009 Jul;57(7):651-8.
5
Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.纤维蛋白肽 A 的释放对于具有 A:a 相互作用受损的变异纤维蛋白原的聚合中 B:b 相互作用的有效形成是必要的。
Thromb Haemost. 2013 Feb;109(2):221-8. doi: 10.1160/TH12-09-0684. Epub 2012 Dec 13.
6
An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.工程化纤维蛋白原变体 AαQ328,366P 不能正常聚合,但保留形成α交叉连接的能力。
Thromb Haemost. 2013 Feb;109(2):199-206. doi: 10.1160/TH12-08-0609. Epub 2012 Dec 6.
7
The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).纤维蛋白原D结构域分子间缔合位点在纤维蛋白和纤维蛋白原东京II(γ275精氨酸→半胱氨酸)聚合中的作用
J Clin Invest. 1995 Aug;96(2):1053-8. doi: 10.1172/JCI118091.
8
Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.重组γT305A纤维蛋白原表明,由于“A”孔和钙结合位点的异常功能,纤维蛋白聚合严重受损。
Thromb Res. 2014 Aug;134(2):518-25. doi: 10.1016/j.thromres.2014.06.002. Epub 2014 Jun 11.
9
Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.杂合子变异纤维蛋白原 γA289V(金泽 III 型)通过血浆和重组纤维蛋白原被确认为低纤维蛋白原血症。
Int J Lab Hematol. 2020 Apr;42(2):190-197. doi: 10.1111/ijlh.13152. Epub 2020 Jan 20.
10
B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.B:b相互作用对于具有受损“a”孔的变异纤维蛋白原的聚合至关重要。
J Thromb Haemost. 2007 Dec;5(12):2352-9. doi: 10.1111/j.1538-7836.2007.02793.x. Epub 2007 Oct 8.

引用本文的文献

1
Fibrinogen Oxidation and Thrombosis: Shaping Structure and Function.纤维蛋白原氧化与血栓形成:塑造结构与功能
Antioxidants (Basel). 2025 Mar 26;14(4):390. doi: 10.3390/antiox14040390.
2
Fibrinogen post-translational modifications are biochemical determinants of fibrin clot properties and interactions.纤维蛋白原的翻译后修饰是纤维蛋白凝块特性及相互作用的生化决定因素。
FEBS J. 2025 Jan;292(1):11-27. doi: 10.1111/febs.17236. Epub 2024 Aug 23.
3
Pediatric patient with fibrinogen Villeurbanne II presenting with an unprovoked portal vein thrombosis.
患有纤维蛋白原维勒班 II 型的儿科患者出现自发性门静脉血栓形成。
Blood Adv. 2022 Jul 26;6(14):4297-4300. doi: 10.1182/bloodadvances.2022006992.
4
Fibrinogen Hershey IV: a novel dysfibrinogen with a gammaV411I mutation in the integrin alpha(IIb)beta(3) binding site.纤维蛋白原赫尔希IV:一种在整合素α(IIb)β(3)结合位点具有γV411I突变的新型异常纤维蛋白原。
Thromb Haemost. 2008 Jun;99(6):1008-12. doi: 10.1160/TH07-06-0427.